H

Hyloris Pharmaceuticals
HYL

Last Price

Balance Sheet

Assets
Metric20162017201820192020202120222023LTM
30.406M24.15M
3.565M4.858M
00
594K191K
743K508K
35.308M29.707M
2.153M1.992M
3.828M3.838M
4.801M3.748M
00
1.591M2.05M
12.373M11.628M
00
47.681M41.335M
Liabilities
Metric20162017201820192020202120222023LTM
3.202M3.428M
116K0K
00
241K326K
00
00
3.2M3.408M
6.759M7.162M
00
1.51M1.489M
00
00
343K541K
1.853M2.03M
00
8.612M9.192M
Equity
Metric20162017201820192020202120222023LTM
00
00
140K140K
-80.761M-86.47M
121.513M121.513M
-1.823M-3.516M
0K476K
39.069M32.143M
00
39.069M32.143M
47.681M41.335M
Other
Metric20162017201820192020202120222023LTM
4.801M4.304M
1.751M1.815M
-28.655M-21.779M

Balance Sheet Composition

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.